Original language | English |
---|---|
Pages (from-to) | 2794-2798 |
Number of pages | 5 |
Journal | Haematologica |
Volume | 108 |
Issue number | 10 |
DOIs |
|
Publication status | Published - Oct 2023 |
Measurable residual disease-guided therapy in intermediate-risk acute myeloid leukemia patients is a valuable strategy in reducing allogeneic transplantation without negatively affecting survival
Jesse M. Tettero, Lok Lam Ngai, Costa Bachas, Dimitri A. Breems, Thomas Fischer, Bjorn T. Gjertsen, Patrycja Gradowska, Laimonas Griskevicius, Jeroen J.W.M. Janssen, Gunnar Juliusson, Johan Maertens, Markus G. Manz, Thomas Pabst, Jakob Passweg, Kimmo Porkka, Peter J.M. Valk, Bob Löwenberg, Gert J. Ossenkoppele, Jacqueline Cloos
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
10
Citations
(Scopus)
25
Downloads
(Pure)